The Health Resources and Services Administration today announced that it will delay the withdrawal of HPSAs designated as "proposed for withdrawal" by one year. According to the agency, “Given the COVID-19 pandemic's impact on the health workforce and health care service delivery, HRSA is providing a longer transition time for jurisdictions and facilities to prepare for potential change of HPSA designations. HPSA designations that are currently proposed for withdrawal will remain in this status until they are re-evaluated in preparation for the publication of the 2023 HPSA Federal Register Notice.” 

AHA in January urged the agency to delay the effective withdrawal date for HPSAs designated as “proposed for withdrawal” by at least one year. 
 

Headline
The AHA Aug. 13 responded to a Food and Drug Administration request for input on the risks and benefits to health and safety associated with non-device…
Headline
In this conversation, Jennifer Bollinger, chief consumer and brand officer at Sutter Health, discusses how a “phygital ecosystem” approach creates a seamless…
Headline
The AHA will host a webinar Aug. 19 at 1 p.m. ET on how to implement behavioral threat assessment and management programs to address workforce violence risks,…
Headline
In this conversation, Jackie Gerhart, M.D., chief medical officer at Epic, Thomas McGinn, M.D., chief physician executive officer at CommonSpirit Health,…
Headline
Leslie Clayton, program director for advanced practice provider service at M Health Fairview and chair of the AHA’s APP Leadership Advisory Group, explains why…
Headline
The AHA July 27 expressed support for the National Nursing Workforce Center Act of 2025 (S. 1482), legislation that would establish state-based nursing…